BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25851994)

  • 1. MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer.
    Zhang L; Ma P; Sun LM; Han YC; Li BL; Mi XY; Wang EH; Song M
    Mol Carcinog; 2016 May; 55(5):768-77. PubMed ID: 25851994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells.
    Flores-Pérez A; Marchat LA; Rodríguez-Cuevas S; Bautista VP; Fuentes-Mera L; Romero-Zamora D; Maciel-Dominguez A; de la Cruz OH; Fonseca-Sánchez M; Ruíz-García E; la Vega HA; López-Camarillo C
    BMC Cancer; 2016 Jul; 16():379. PubMed ID: 27377268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.
    Browne G; Dragon JA; Hong D; Messier TL; Gordon JA; Farina NH; Boyd JR; VanOudenhove JJ; Perez AW; Zaidi SK; Stein JL; Stein GS; Lian JB
    Tumour Biol; 2016 Jul; 37(7):8825-39. PubMed ID: 26749280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo.
    Mohammadi-Yeganeh S; Hosseini V; Paryan M
    J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.
    Zhou W; Song F; Wu Q; Liu R; Wang L; Liu C; Peng Y; Mao S; Feng J; Chen C
    PLoS One; 2017; 12(4):e0176395. PubMed ID: 28437471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
    Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
    Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit tumor growth of human triple negative breast cancer.
    Zhu Z; Wang S; Zhu J; Yang Q; Dong H; Huang J
    Biol Chem; 2016 Oct; 397(10):1087-95. PubMed ID: 27186677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
    BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
    Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
    Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
    Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z
    Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration.
    Song GQ; Zhao Y
    Tumour Biol; 2015 Jul; 36(7):5001-9. PubMed ID: 25680404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-182 targets FOXF2 to promote the development of triple-negative breast cancer.
    Yu J; Shen W; Gao B; Zhao H; Xu J; Gong B
    Neoplasma; 2017; 64(2):209-215. PubMed ID: 28043147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
    Chen F; Luo N; Hu Y; Li X; Zhang K
    Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1.
    Wang Y; Zhang Z; Wang J
    Oncol Rep; 2018 Jun; 39(6):2563-2574. PubMed ID: 29693185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27.
    Ren YQ; Fu F; Han J
    Med Sci Monit; 2015 May; 21():1297-303. PubMed ID: 25943633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.